Creative Medical Technology Holdings, Inc. Diluted Shares Outstanding (Weighted Average)
Creative Medical Technology Holdings, Inc. (CELZ) reported Diluted Shares Outstanding (Weighted Average) of 3.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 3.70M shares, a 43.45% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 3.70M shares, a 86.88% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 2.68M shares, a 57.63% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.58M shares, a 85.35% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 2.38M shares, a 60.95% increase from fiscal 2024.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.48M shares, a 5.17% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.41M shares, a 87.12% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 10.93M shares, a 236.51% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.70M shares 10-Q · filed 2026-08-07 | 3.70M shares 10-Q · filed 2026-08-07 | 3.36M shares derived: average of 3 quarters · filed 2026-08-07 | 3.17M shares derived: average of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | 3.70M shares 10-Q · filed 2026-05-08 | 3.19M shares derived: average of 2 quarters · filed 2026-05-08 | 2.99M shares derived: average of 3 quarters · filed 2026-05-08 | 2.89M shares derived: average of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | 2.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 2.63M shares derived: average of 2 quarters · filed 2026-03-20 | 2.62M shares derived: average of 3 quarters · filed 2026-08-07 | 2.38M shares 10-K · filed 2026-03-20 | |||
| 2025-09-30 | 2.58M shares 10-Q · filed 2025-11-07 | 2.58M shares derived: average of 2 quarters · filed 2026-08-07 | 2.28M shares 10-Q · filed 2025-11-07 | 2.21M shares derived: average of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | 2.58M shares 10-Q · filed 2026-08-07 | 2.28M shares 10-Q · filed 2026-08-07 | 2.09M shares derived: average of 3 quarters · filed 2026-08-07 | 1.91M shares derived: average of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | 1.98M shares 10-Q · filed 2026-05-08 | 1.84M shares derived: average of 2 quarters · filed 2026-05-08 | 1.69M shares derived: average of 3 quarters · filed 2026-05-08 | 1.62M shares derived: average of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | 1.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 1.55M shares derived: average of 2 quarters · filed 2026-03-20 | 1.50M shares derived: average of 3 quarters · filed 2026-03-20 | 1.48M shares 10-K · filed 2026-03-20 | |||
| 2024-09-30 | 1.39M shares 10-Q · filed 2025-11-07 | 1.40M shares derived: average of 2 quarters · filed 2025-11-07 | 1.41M shares 10-Q · filed 2025-11-07 | ||||
| 2024-06-30 | 1.41M shares 10-Q · filed 2025-08-08 | 1.41M shares 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | 1.42M shares 10-Q · filed 2025-05-09 | ||||||
| 2023-12-31 | 1.41M shares 10-K · filed 2025-03-14 | ||||||
| 2022-12-31 | 14.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 14.09M shares derived: average of 2 quarters · filed 2023-03-31 | 10.93M shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 14.07M shares 10-Q · filed 2022-11-10 | 9.87M shares 10-Q · filed 2022-11-10 | |||||
| 2021-12-31 | 5.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 4.18M shares derived: average of 2 quarters · filed 2023-03-31 | -410.50M shares derived: average of 3 quarters · filed 2023-03-31 | 3.25M shares 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 2.45M shares 10-Q · filed 2022-11-10 | -618.71M shares derived: average of 2 quarters · filed 2022-11-10 | 2.36M shares 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -1.24B shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 2.33M shares 10-Q · filed 2022-08-12 | 1.16B shares 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | 1.24B shares 10-Q · filed 2022-05-13 | ||||||
| 2020-09-30 | 2.45M shares 10-Q · filed 2021-11-15 | 1.36B shares 10-Q · filed 2020-11-13 | 85.81M shares derived: average of 2 quarters · filed 2021-11-15 | 2.14M shares 10-Q · filed 2021-11-15 | 1.07B shares 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | 169.16M shares 10-Q · filed 2020-08-14 | 960.39M shares 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | 776.60M shares 10-Q · filed 2021-05-17 | ||||||
| 2019-06-30 | 7.10M shares 10-Q · filed 2020-08-14 | 6.77M shares 10-Q · filed 2020-08-14 | |||||
| 2019-03-31 | 6.44M shares 10-Q · filed 2020-05-15 | ||||||
| 2012-12-31 | 18.11M shares 10-K · filed 2013-03-15 | ||||||
| 2011-12-31 | 18.11M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |